Abstract:Objective To investigate the expressions and clinical significance of serum anti - acetylcholine receptor antibodies (AChR-Ab), anti-Titin antibodies (Titin-Ab), and anti-Ryanodine receptor antibodies (RyR-Ab) in patients with myasthenia gravis (MG). Methods Serum AChR-Ab, Titin-Ab and RyR-Ab were detected with enzyme-linked immunosorbent assay (ELISA) in 182 MG patients, 105 patients of other neurological diseases (OND) and 62 normal controls. Results Serum AChR-Ab, Titin-Ab and RyR-Ab were detected positive respectively in 68.13% (124/182), 64.29% (117/182) and 67.03% (122/182) of patients in MG group. The positive rates of those antibodies in MG group were significantly higher than those in OND group (P = 0.000, for all) and control group (P = 0.000, for all). When 3 antibodies coexisted, the sensitivity in the diagnosis of MG was 41.21%, with 99.40% of specificity. There was no significant difference in the positive rate of serum AChR-Ab, Titin-Ab and RyR-Ab between early-onset MG subgroup and late-onset MG subgroup (P > 0.05, for all). The positive rates of AChR-Ab were significantly higher in MG patients with thymoma than in those without thymoma (P = 0.004). There was no significant difference in the positive rate of Titin-Ab and RyR-Ab between MG with thymoma subgroup and MG without thymoma subgroup (P > 0.05, for all). The prevalence of AChR-Ab in generalized MG (GMG) atients (Ⅱa and Ⅱb) was higher than those in ocular MG (OMG) patients (typeⅠ; P = 0.005, 0.012). There was no significant difference in the positive rate of Titin-Ab and RyR-Ab between GMG subgroup and OMG subgroup (P > 0.05, for all). Conclusions Serum AChR-Ab, Titin-Ab and RyR-Ab can be used as ndicators of the diagnosis of MG. Patients with 3 coexisted positive antibodies are highly suspected as MG. Higher AChR-Ab level in serum of OMG patients indicates the possibility of progressing to GMG. DOI: 10.3969/j.issn.1672-6731.2016.10.007

The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.

Titin antibody in myasthenia gravis and its clinical significance

Thymic Expression of the Main Immunogenic Region of Titin in Thymomatous Myasthenia Gravis

The Clinical Significance of Serum Anti-Titin Antibody Test in Patients with Myasthenia Gravis

Serum Titin antibody and Ryanodine receptor antibody in patients with myasthenia gravis

The Significance of Serum Anti-Titin Antibodies and Anti-Acetylcholine Receptor Antibodies in Patients with Myasthenia Gravis

Non-neuronal cholinergic activity is potentiated in myasthenia gravis

Detection and Clinical Significance of Serum Autoantibodies in Patients with Myasthenia Gravis

Detection of Multiple Antibodies in Myasthenia Gravis and Its Clinical Significance

Clinical significance of serum antibodies in different types of myasthenia gravis

Detection of Four Serum Antibodies in Myasthenia Gravis Patients and Its Clinical Values

Detection of Ryanodine receptor antibody in sera of myasthenia gravis patients and its clinical significance

Prognostic Analysis of Thymoma-Associated Myasthenia Gravis (MG) in Chinese Patients and Its Implication of MG Management: Experiences from a Tertiary Hospital

Augmentation Of Circulating Follicular Helper T Cells And Their Impact On Autoreactive B Cells In Myasthenia Gravis

Thyroid Function and Circulating Antithyroid Antibodies in Myasthenia Gravis

[Distribution Characteristics and Correlation Analysis of Antibody Detection Value in Myasthenia Gravis].

Anti-presynaptic membrane receptor antibodies in myasthenia gravis.

Increased Frequency of Thymic T Follicular Helper Cells in Myasthenia Gravis Patients with Thymoma

Plasma Levels and Clinical Significance of Complement Activation Products in Generalized Myasthenia Gravis Patients with Acetylcholine Receptor Antibodies

Myasthenia Gravis: T and B Cell Reactivities to the Β-Bungarotoxin Binding Protein Presynaptic Membrane Receptor

Decrease of CD4+CD25highFoxp3+ regulatory T cells and elevation of CD19+BAFF-R+ B cells and soluble ICAM-1 in myasthenia gravis